INDOCO REMEDIES
|
The Current P/E Ratio of INDOCO REMEDIES is -15.39.
| Share Price | ₹194.1 | Mar 09,2026 |
| Market Cap | ₹1,791.1 Cr | |
| Earnings-TTM | ₹-116.4 Cr | TTM-Consolidated Results |
| Price/Earnings | -15.39x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of INDOCO REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,791.1 Cr] as on Mar 09,2026
(/) Earnings [ ₹-116.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -15.39x ]
Thus, for INDOCO REMEDIES , the investors are currently willing to pay -15.39 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDOCO REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDOCO REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of INDOCO REMEDIES
PE Ratio Performance Analysis for INDOCO REMEDIES
- INDOCO REMEDIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 20.57x.
- INDOCO REMEDIES 's operated at median p/e ratio of 22.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDOCO REMEDIES 's p/e ratio peaked in Mar2024 at 30.76x.
- INDOCO REMEDIES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does INDOCO REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| INDOCO REMEDIES | -116.35 | -15.39 | 1,791.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 39.42 | 433,704.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 67.86 | 168,223.0 |
| CIPLA LTD | 4,544.70 | 23.55 | 107,043.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 65.11 | 147,928.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.49 | 107,368.0 |
| MANKIND PHARMA LTD | 1,796.65 | 49.68 | 89,250.5 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.53 | 91,431.5 |
| LUPIN LTD | 4,669.18 | 22.53 | 105,198.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 20.62 | 72,426.0 |
| ABBOTT INDIA LTD | 1,524.13 | 37.86 | 57,710.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDOCO REMEDIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -15.39x |
| Max industry PE | 67.86x |
| Median industry PE | 23.55x |
| Average industry PE | 31.75x |
You may also like the below Video Courses